The most expensive number in gummy manufacturing is not the one everyone argues about. According to Azuca CEO and co founder Kim Sanchez Rael, the price of the infusion ingredient tells only part of the story. The rest lives in drying time, yield, waste, labor, and whether the finished product still looks and tastes right after months on a shelf.
That is the argument she made in a sponsored interview with IgniteIt, and it is worth hearing regardless of who paid for the microphone. Azuca’s TiME INFUSION technology has powered more than 800 million servings through over 150 partner licenses, which means Rael has seen the economics play out at real scale.
What does a gummy actually cost to make?
Start with the finished product and work backward. That is Rael’s method. Manufacturers comparing infusion systems tend to fixate on the ingredient price, and she says that misses where the money really goes. Yield. Drying time. Throughput. Waste. Equipment requirements. Labor. Shelf stability.
Gummy manufacturing is unusually sensitive to formulation changes. Water activity, Brix, gel structure, texture, and shelf stability all move when you change the recipe, and some emulsion based systems add water that creates real problems in high solids formulations. The cost of a bad formulation choice does not show up in the ingredient invoice. It shows up six months later in returns.
How does Azuca’s licensing model change the math?
Instead of making every production run itself, Azuca licenses its formulations and supplies its ACTiVATOR ingredients while manufacturers run production on site with pre programmed equipment. Partners control their own dosing and volumes.
That structure matters for one reason: it lets manufacturers standardize an infusion process across state regulated markets without heavy upfront capital. For multi state operators, that is the difference between a technology that works in one facility and one that works in all of them. Whether it improves margins still depends on each operation’s economics, which is the honest caveat Rael keeps attached to every claim.
What does the consumer research show?
In a blind panel comparison, 86 percent of participants rated TiME INFUSION gummies good or very good on taste, versus 60 percent for nano emulsion gummies at the same flavor and dose. The TiME gummies also scored higher on texture, effects, overall liking, and purchase intent.
The results are company reported, so read them with that lens. But the underlying point stands and it connects directly to what the science says about fast acting edibles. Fast onset is only half the product. If it tastes bad, nobody buys the second pack.
What should manufacturers demand before switching?
Rael’s checklist is the most useful part of the interview. Demand documentation on ingredient specs, contaminant testing, manufacturing quality systems, and stability. Validate potency consistency and dosing on your own equipment with your own recipes. Run a pilot and measure more than the dose: taste, texture, onset, yield, throughput, drying time, waste, production efficiency, and stability across the intended shelf life.
Her commercialization rule is three words: nail it and scale it. A system is ready when a manufacturer can show consistent dosing, preserved product integrity, stable performance over time, solid economics, and a repeatable process. That is the same discipline behind making 100,000 gummies the hard part instead of the easy part, and the formulation discipline that decides which products earn their shelf space.
The question is never what the infusion costs. It is what value it creates.
FAQs
- Who is Kim Sanchez Rael?
CEO and co founder of Azuca, the company behind the TiME INFUSION cannabinoid infusion technology for cannabis manufacturers. - What drives gummy manufacturing costs?
Yield, drying time, throughput, waste, equipment requirements, labor, and shelf stability. The infusion ingredient price is only one input. - How does Azuca’s licensing model work?
Azuca licenses its formulations and supplies its ACTiVATOR ingredients while manufacturers run production on site with pre programmed equipment, keeping control of dosing and volume. - What did the consumer research find?
In a blind panel, 86 percent rated TiME INFUSION gummies good or very good on taste versus 60 percent for the nano emulsion comparator, with higher texture, effects, liking, and purchase intent. Results are company reported. - When is a product ready to scale?
Rael’s rule is ‘nail it and scale it’: consistent dosing, preserved product integrity, stable performance over time, solid economics, and a repeatable process.
Source: IgniteIt: The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale.